Article Details
Retrieved on: 2022-11-29 08:04:57
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Chardan Capital upped their target price on shares of PDS Biotechnology from $15.00 to $16.00 and gave the stock a buy rating in a research report on ...
Article found on: reporter.am
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here